
Nemaura Medical NMRD
Quartalsbericht 2023-Q4
hinzugefügt 12.02.2024
Land |
|
IPO-Jahr |
- |
Branche |
Medizinische Geräte |
Börse |
NASDAQ CAPITAL |
Anteile |
24.9 M |
Marktkapitalisierung |
$ 2.74 M |
EBITDA (LTM) |
$ -7.05 M |
P/E (LTM) |
- |
P/S (LTM) |
8.18 |
EPS (LTM) |
-0.28 |
Andere Aktien der Branche "Medizinische Geräte"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
$ 176.83 | 5.97 % | $ 13.2 B | Nasdaq Global Select Market,SPB | ||
|
Alphatec Holdings
ATEC
|
$ 11.66 | 5.71 % | $ 1.75 B | Nasdaq Global Select Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
AxoGen
AXGN
|
$ 34.0 | 9.71 % | $ 1.57 B | Nasdaq Capital Market,SPB | ||
|
AdaptHealth Corp.
AHCO
|
$ 12.18 | 2.01 % | $ 1.65 B | Nasdaq Capital Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Bio-Rad Laboratories
BIO
|
$ 281.15 | 1.13 % | $ 7.93 B | NYSE,SPB | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.62 | 1.67 % | $ 38.6 M | Nasdaq Capital Market | ||
|
Bruker Corporation
BRKR
|
$ 38.25 | 4.31 % | $ 5.7 K | Nasdaq Global Select Market,SPB | ||
|
Boston Scientific Corporation
BSX
|
$ 62.56 | 1.15 % | $ 92.6 B | NYSE,SPB | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Electromed
ELMD
|
$ 24.4 | 2.61 % | $ 206 M | NYSE American | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
ClearPoint Neuro
CLPT
|
$ 9.17 | 1.1 % | $ 260 M | Nasdaq Capital Market | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Globus Medical
GMED
|
$ 91.96 | 2.13 % | $ 12.4 B | NYSE,SPB | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Inogen
INGN
|
$ 6.67 | -1.91 % | $ 177 M | Nasdaq Global Select Market,SPB | ||
|
Inspire Medical Systems
INSP
|
$ 53.38 | -1.89 % | $ 1.57 B | NYSE,SPB | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
IRIDEX Corporation
IRIX
|
$ 1.03 | - | $ 17.4 M | Nasdaq Global Select Market | ||
|
Integer Holdings Corporation
ITGR
|
$ 87.48 | 2.78 % | $ 3.04 B | NYSE,SPB | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 16.01 | 1.59 % | $ 376 M | Nasdaq Global Select Market,SPB | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
LivaNova PLC
LIVN
|
$ 64.66 | 1.76 % | $ 3.53 B | Nasdaq Global Select Market | ||
|
LENSAR
LNSR
|
$ 5.53 | -1.78 % | $ 66.1 M | Nasdaq Capital Market | ||
|
Butterfly Network
BFLY
|
$ 4.14 | 2.22 % | $ 876 M | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.37 | -0.88 % | $ 126 M | Nasdaq Global Market | ||
|
Myomo
MYO
|
$ 0.68 | 0.44 % | $ 28.5 M | NYSE American | ||
|
NanoVibronix
NAOV
|
- | - | $ 1.08 M | Nasdaq Global Select Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Delcath Systems
DCTH
|
$ 9.85 | 1.86 % | $ 353 M | Nasdaq Capital Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Natus Medical Incorporated
NTUS
|
- | 1.94 % | $ 1.05 B | Nasdaq Global Select Market,SPB | ||
|
Nevro Corp.
NVRO
|
- | - | $ 217 M | NYSE,SPB |